Drug Profile
REN 850
Alternative Names: Leukocyte trafficking inhibitorLatest Information Update: 15 Jun 2005
Price :
$50
*
At a glance
- Originator Renovis
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Multiple sclerosis
Most Recent Events
- 13 Jun 2005 Discontinued - Phase-I for Multiple sclerosis in USA (PO)
- 13 Jun 2005 Discontinued - Preclinical for Autoimmune disorders in USA (PO)
- 14 Feb 2005 Phase-I clinical trials in Multiple sclerosis in USA (PO)